Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
administered, advisor, AERCO, AgroFresh, air, alumina, appliance, avoid, banc, bankruptcy, basic, Behrend, binding, borohydride, Brazilian, breast, CADE, Central, Chairman, Chapter, clean, clear, Comcast, comment, companion, compelling, contrary, Coodetec, correct, corrected, Council, coupled, Ct, David, deregulation, dismissing, Duo, en, ExxonMobil, Fitterling, fleet, Fort, Harlan, horticulture, Howard, implant, Jersey, Jim, Joe, Kepler, midst, OLED, opposing, panel, passenger, patent, precedent, priority, pulp, railcar, reargument, rehear, reheard, rehearing, Saskatchewan, senior, sodium, softening, split, stabilization, Sustainability, switch, TCEQ, tenor, Ungerleider, unknowable, unsecured, voluntarily, wastewater, Weed, Weideman, William
Removed:
appealing, high, ion, light, monoethylene, Plaquemine, printed, stronger
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 12.1 Computation of Ratio of Earnings to Fixed Charges
- 23 Analysis, Research & Planning Corporation's Consent
- 31 Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31 Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32 Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32 Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Dow Chemical similar filings
Filing view
External links
Analysis, Research & Planning Corporation's Consent | EXHIBIT 23 |
The Dow Chemical Company:
Analysis, Research & Planning Corporation (“ARPC”) hereby consents to the use of ARPC's name and the reference to ARPC's reports in this Quarterly Report on Form 10-Q of The Dow Chemical Company for the period ended September 30, 2014, and the incorporation by reference thereof in the following Registration Statements of The Dow Chemical Company:
Form S-3: | |
No. | 333-186728 |
Form S-4: | |
No. | 333-88443 |
Form S-8: | |
Nos. | 2-64560 |
33-21748 | |
33-51453 | |
33-52841 | |
33-58205 | |
33-61795 | |
333-27381 | |
333-40271 | |
333-43730 | |
333-49183 | |
333-67414 | |
333-88443 | |
333-91027 | |
333-103518 | |
333-103519 | |
333-105080 | |
333-115185 | |
333-122932 | |
333-145015 | |
333-162910 | |
333-181356 | |
333-191979 |
/s/ B. THOMAS FLORENCE |
B. Thomas Florence |
President |
Analysis, Research & Planning Corporation |
October 24, 2014 |
60